Literature DB >> 17590955

Apoptosis induction and DNA interstrand cross-link formation by cytotoxic trans-[PtCl2(NH(CH3)2)(NHCH(CH3)2) : cross-linking between d(G) and complementary d(C) within oligonucleotide duplexes.

Eva I Montero1, José M Pérez, Annie Schwartz, Miguel A Fuertes, Jean M Malinge, Carlos Alonso, Marc Leng, Carmen Navarro-Ranninger.   

Abstract

We have investigated the cytotoxic activity, the induction of apoptosis, and the interstrand cross-linking efficiency in the A2780cisR ovarian tumor cell line, after replacement of the two NH3 nonleaving groups in trans-[PtCl2(NH3)2] (trans-DDP) by dimethylamine and isopropylamine. The data show that trans-[PtCl2(NH(CH)2)(NHCH(CH3)2)] is able to circumvent resistance to cis-[PtCl2(NH3)2] (cis-DDP, cisplatin) in A2780cisR cells. In fact, trans-[PtCl2(NH(CH3)2)(NHCH(CH3)2)] shows a cytotoxic potency higher than that of cis-DDP and trans-DDP, with the mean IC50 values being 11, 58, and 300 microM, respectively. In addition, at equitoxic doses (concentrations of the platinum drugs equal to their IC50 values) and after 24 hours of drug treatment, the level of induction of apoptosis by trans-[PtCl2(NH(CH3)2)(NHCH(CH3)2)] is twice that produced by cis-DDP. Under the same experimental conditions, trans-DDP does not induce significant levels of apoptosis in A2780cisR cells. After 24 hours of incubation of A2780cisR cells at concentrations equal to the IC0o value of the platinum drugs, the level of DNA interstrand cross-links (ICLs) induced by trans-[PtCI2(NH(CH)2)(NHCH(CH3)] is two and three times higher, respectively, than those induced by cis-DDP and trans-DDP. We also found that trans-[PtCl2(NH(CH3)2)(NHCH(CH3)2)] formed DNA ICLs between guanine and complementary cytosine. We propose that, in A2780cisR cells, the induction of apoptosis by trans-[PtCl2(NH(CH3)2)(NHCH(CH3)2)] is related to its greater ability (relative to cis-DDP and trans-DDP) to form DNA ICLs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 17590955     DOI: 10.1002/1439-7633(20020104)3:1<61::AID-CBIC61>3.0.CO;2-I

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  6 in total

1.  Proteins as possible targets for cytotoxic trans-platinum(II) complexes with aliphatic amine ligands: Further exceptions to the DNA paradigm.

Authors:  Leticia Cubo; Michael Groessl; Paul J Dyson; Adoración G Quiroga; Carmen Navarro-Ranninger; Angela Casini
Journal:  ChemMedChem       Date:  2010-08-02       Impact factor: 3.466

Review 2.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

3.  Syntheses and characterization of vitamin B12-Pt(II) conjugates and their adenosylation in an enzymatic assay.

Authors:  Pilar Ruiz-Sánchez; Stefan Mundwiler; Bernhard Spingler; Nicole R Buan; Jorge C Escalante-Semerena; Roger Alberto
Journal:  J Biol Inorg Chem       Date:  2007-12-04       Impact factor: 3.358

4.  Promotion of DNA strand breaks, interstrand cross-links and apoptotic cell death in A2780 human ovarian cancer cells by transplatinum planar amine complexes.

Authors:  Sheena M Aris; David A Gewirtz; John J Ryan; Kenneth M Knott; Nicholas P Farrell
Journal:  Biochem Pharmacol       Date:  2007-02-28       Impact factor: 5.858

5.  Trans-platinum(II) complexes with cyclohexylamine as expectator ligand induce necrosis in tumour cells by inhibiting DNA synthesis and RNA transcription.

Authors:  V Cepero; B García-Serrelde; V Moneo; F Blanco; A M González-Vadillo; A Alvarez-Valdés; C Navarro-Ranninger; A Carnero
Journal:  Clin Transl Oncol       Date:  2007-08       Impact factor: 3.340

6.  Ruthenium polypyridyl complexes and their modes of interaction with DNA: is there a correlation between these interactions and the antitumor activity of the compounds?

Authors:  Eva Corral; Anna C G Hotze; Hans den Dulk; Anna Leczkowska; Alison Rodger; Michael J Hannon; Jan Reedijk
Journal:  J Biol Inorg Chem       Date:  2008-12-16       Impact factor: 3.358

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.